Systemic lupus erythematosus, regulatory T cells and pregnancy

Expert Review of Clinical Immunology

Volumn 7, Issue 5, 2011, Pages 635-648

  Varghese, Stephy ^a   Crocker, Ian ^a   Bruce, Ian N ^a,b   Tower, Clare ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

immune tolerance; pregnancy; systemic lupus erythematosus; T regulatory cells

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 8; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTING CELL; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; DECIDUALIZATION; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMPLANTATION; IPEX SYNDROME; MACROPHAGE; MICROVILLUS; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PLACENTA DEVELOPMENT; PREGNANCY; PREGNANCY COMPLICATION; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL;

ANIMALS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; T-LYMPHOCYTES, REGULATORY;

EID: 80052622186     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.59     Document Type: Review

References (157)

1. D'cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 369(9561), 587-596 (2007). (Pubitemid 46241445)
2. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15(5), 308-318 (2006). (Pubitemid 43828810)
3. Nelson-Piercy C. Handbook of Obstetric Medicine (Third Edition).Informa Healthcare, London, UK, 140-145 (2006).
4. Madazli R, Bulut B, Erenel H, Gezer A, Guralp O. Systemic lupus erythematosus and pregnancy. J. Obstet. Gynaecol. 30(1), 17-20 (2010).
5. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin. J. Am. Soc. Nephrol. 5(11), 2060-2068 (2010).
6. Dorling J. Centre for Maternal and Child Enquiries (CMACE) Perinatal Mortality 2008: United Kingdom. CMACE, London, UK (2010).
7. Kontaki E, Boumpas DT. Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids. J. Autoimmun. 35(3), 206-211 (2010).
8. Veenstra Van Nieuwenhoven AL, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum. Reprod. Update 9(4), 347-357 (2003). (Pubitemid 36987283)
9. Ohkura N, Sakaguchi S. Regulatory T cells: roles of T cell receptor for their development and function. Semin. Immunopathol. 32(2), 95-106 (2010).
10. Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 42(6), 1219-1227 (1999). (Pubitemid 29268959)
11. Finkelsztejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 118(7), 790-797 (2011).
12. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. 7, 320-338 (1953).
13. Chaouat G, Kolb JP, Wegmann TG. The murine placenta as an immunological barrier between the mother and the fetus. Immunol. Rev. 75, 31-60 (1983). (Pubitemid 13008733)
14. Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 21(24), 3352-3357 (2003). (Pubitemid 36792085)
15. Lyall F. The human placental bed revisited. Placenta 23(8-9), 555-562 (2002). (Pubitemid 37184664)
16. Yoshinaga K. Research on blastocyst implantation essential factors (BIEFs).Am. J. Reprod. Immunol. 63(6), 413-424 (2010).
17. Dimitriadis E, Nie G, Hannan NJ, Paiva P, Salamonsen LA. Local regulation of implantation at the human fetal-maternal interface. Int. J. Dev. Biol. 54(2-3), 313-322 (2010).
18. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2(9), 656-663 (2002). (Pubitemid 37328723)
19. Abrahams VM, Kim YM, Straszewski SL, Romero R, Mor G. Macrophages and apoptotic cell clearance during pregnancy. Am. J. Reprod. Immunol. 51(4), 275-282 (2004). (Pubitemid 38455729)
20. Tabiasco J, Rabot M, Aguerre-Girr M et al. Human decidual NK cells: unique phenotype and functional properties - a review. Placenta 27(Suppl. A), S34-S39 (2006).
21. Cartwright JE, Fraser R, Leslie K, Wallace AE, James JL. Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders. Reproduction 140(6), 803-813 (2010).
22. Nagamatsu T, Schust DJ. The contribution of macrophages to normal and pathological pregnancies. Am. J. Reprod. Immunol. 63(6), 460-471 (2010).
23. Mizuno M, Aoki K, Kimbara T. Functions of macrophages in human decidual tissue in early pregnancy. Am. J. Reprod. Immunol. 31(4), 180-188 (1994). (Pubitemid 24159026)
24. Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O. Phenotypic characterization of human decidual macrophages. Clin. Exp. Immunol. 131(3), 498-505 (2003). (Pubitemid 36324142)
25. Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol. 136(2), 373-378 (2004). (Pubitemid 38543459)
26. Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281(5380), 1191-1193 (1998). (Pubitemid 28406294)
27. Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am. J. Pathol. 174(5), 1959-1971 (2009).
28. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens 63(1), 1-12 (2004). (Pubitemid 38130436)
29. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30(6), 1538-1543 (2000). (Pubitemid 30342794)
30. +CD25- T cells. J. Clin. Invest. 112(9), 1437-1443 (2003). (Pubitemid 38057697)
31. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31(4), 1247-1254 (2001).
32. Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166(6), 3789-3796 (2001). (Pubitemid 32224903)
33. + regulatory T cells. Nat. Immunol. 4(4), 330-336 (2003). (Pubitemid 36432314)
34. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science 299(5609), 1057-1061 (2003). (Pubitemid 36222930)
35. + T regulatory cells. Nat. Immunol. 4(4), 337-342 (2003). (Pubitemid 36432315)
36. + regulatory T cells at the single-cell level. Eur. J. Immunol. 35(6), 1681-1691 (2005). (Pubitemid 40862316)
37. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100(5), 731-737 (1982). (Pubitemid 12155977)
38. Seddiki N, Santner-Nanan B, Martinson J et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203(7), 1693-1700 (2006). (Pubitemid 44036275)
39. + Treg cells. J. Exp. Med. 203(7), 1701-1711 (2006). (Pubitemid 44036276)
40. + regulatory T cells express lower levels of the IL-7 receptor a chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319(1-2), 41-52 (2007). (Pubitemid 46110995)
41. Seddiki N, Santner-Nanan B, Tangye SG et al. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 107(7), 2830-2838 (2006).
42. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115(7), 1953-1962 (2005). (Pubitemid 40979735)
43. Fritzsching B, Oberle N, Pauly E et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 108(10), 3371-3378 (2006).
44. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat. Rev. Immunol. 8(7), 523-532 (2008).
45. + regulatory T cells in the human immune system. Nat. Rev. Immunol. 10(7), 490-500 (2010).
46. + T cells expressing the FOXP3 transcription factor. Immunity 30(6), 899-911 (2009).
47. Ito M, Nakashima A, Hidaka T et al. A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour. J. Reprod. Immunol. 84(1), 75-85 (2010).
48. + regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol. Reprod. 82(4), 698-705 (2010).
49. - T-cells in decidua and maternal blood during human pregnancy. Placenta 27(Suppl. A), S47-S53 (2006).
50. Mold JE, Michaelsson J, Burt TD et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322(5907), 1562-1565 (2008).
51. + T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (FOXP3) gene. Exp. Hematol. 32(7), 622-629 (2004). (Pubitemid 38891531)
52. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5(3), 266-271 (2004). (Pubitemid 38332123)
53. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 178(4), 2572-2578 (2007). (Pubitemid 46233460)
54. Robertson SA, Guerin LR, Moldenhauer LM, Hayball JD. Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid. J. Reprod. Immunol. 83(1-2), 109-116 (2009).
55. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update 15(5), 517-535 (2009).
56. Schumacher A, Brachwitz N, Sohr S et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J. Immunol. 182(9), 5488-5497 (2009).
57. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today 14(7), 353-356 (1993). (Pubitemid 23198169)
58. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today 18(10), 478-482 (1997). (Pubitemid 27441590)
59. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F. Inflammation and pregnancy. Reprod. Sci. 16(2), 206-215 (2009).
60. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Th1/Th2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/ early abortion: reexamining the Th1/Th2 paradigm. Int. Arch. Allergy. Immunol. 134(2), 93-119 (2004). (Pubitemid 38716257)
61. Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum. Reprod. 17(9), 2439-2444 (2002). (Pubitemid 35021472)
62. + regulatory T-cell subset. Immunology 112(1), 38-43 (2004). (Pubitemid 38609820)
63. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 10(5), 347-353 (2004). (Pubitemid 38714366)
64. Chirico DEA. Predictors of pregnancy complications in women with systemic lupus erythematosus. BJOG 116, 1407-1408 (2009).
65. + regulatory T cells in maternal peripheral blood during pregnancy and labor at term and preterm. Clin. Invest. Med. 33(6), E422 (2010).
66. + Tregs in human second trimester pregnancy is induced by progesterone and 17βestradiol. J. Immunol. 183(1), 759-769 (2009).
67. Leber A, Teles A, Zenclussen AC. Regulatory T cells and their role in pregnancy. Am. J. Reprod. Immunol. 63(6), 445-459 (2010).
68. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin. Exp. Immunol. 159(2), 109-119 (2010).
69. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63(6), 601-610 (2010).
70. + T cells in the periphery. Nat. Rev. Immunol. 7(3), 231-237 (2007).
71. + regulatory T cells by TGF-b induction of transcription factor FOXP3. J. Exp. Med. 198(12), 1875-1886 (2003). (Pubitemid 38032120)
72. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441(7090), 235-238 (2006).
73. + Tregs to Th17-like cells in tumor-draining lymph nodes. Blood 113(24), 6102-6111 (2009).
74. Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S. Circulating and decidual Th17 cell levels in healthy pregnancy. Am. J. Reprod. Immunol. 63(2), 104-109 (2010).
75. + T cells in healthy pregnancy but not in preeclampsia. J. Immunol. 183(11), 7023-7030 (2009).
76. Crispin JC, Kyttaris V, Juang YT, Tsokos GC. Systemic lupus erythematosus: new molecular targets. Ann. Rheum. Dis. 66(Suppl. 3), iii65-iii69 (2007).
77. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) 46(7), 1052-1056 (2007). (Pubitemid 47050602)
78. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161(1), 72-87 (1985). (Pubitemid 15169721)
79. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann. Rev. Immunol. 22, 531-562 (2004). (Pubitemid 38680433)
80. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184(2), 387-396 (1996). (Pubitemid 26324092)
81. + T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice. Int. J. Exp. Pathol. 86(5), 289-296 (2005). (Pubitemid 41413624)
82. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177(3), 1451-1459 (2006). (Pubitemid 44092478)
83. Hsu WT, Suen JL, Chiang BL. The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin. Exp. Immunol. 145(3), 513-519 (2006).
84. + regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum. 52(4), 1180-1184 (2005). (Pubitemid 40530125)
85. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/ winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27(1), 68-73 (2001). (Pubitemid 32044521)
86. Riemekasten G, Langnickel D, Enghard P et al. Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J. Immunol. 173(9), 5835-5842 (2004). (Pubitemid 39392174)
87. Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J. Immunol. 178(12), 7849-7858 (2007). (Pubitemid 46898057)
88. Horwitz DA. Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res. Ther. 10(6), 227 (2008).
89. +IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 16(7), 489-496 (2007). (Pubitemid 47242522)
90. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21(3), 273-276 (2003). (Pubitemid 37410115)
91. + regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity 40(7), 521-528 (2007). (Pubitemid 351233173)
92. Miyara M, Amoura Z, Parizot C et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175(12), 8392-8400 (2005). (Pubitemid 41798406)
93. +CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178(4), 2579-2588 (2007). (Pubitemid 46233461)
94. Bonelli M, Savitskaya A, Von Dalwigk K et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).Int. Immunol. 20(7), 861-868 (2008). (Pubitemid 351876312)
95. + T cells in patients with new-onset systemic lupus erythematosus. Ann. Rheum. Dis. 67(7), 1037-1040 (2008). (Pubitemid 351956671)
96. high, CD127-/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 58(7), 2120-2130 (2008). (Pubitemid 351988104)
97. Franz B, Fritzsching B, Riehl A et al. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum. 56(6), 1910-1920 (2007). (Pubitemid 47110390)
98. Yates J, Whittington A, Mitchell P, Lechler RI, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin. Exp. Immunol. 153(1), 44-55 (2008). (Pubitemid 351809334)
99. Mesquita D, de Melo Cruvinel W, Araujo J et al. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells. Scand. J. Rheumatol. 40(1), 41-50 (2011).
100. + expression levels characterize different regulatory T-cell populations in human peripheral blood. J. Invest. Dermatol. 130(2), 492-499 (2010).
101. Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN. Increased expression of the FOXP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin. Immunol. 123(1), 66-73 (2007). (Pubitemid 46401511)
102. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188(2), 287-296 (1998). (Pubitemid 28357757)
103. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10(12), 1969-1980 (1998). (Pubitemid 28566059)
104. + regulatory T cells: independence of IL-2 consumption, TGF-b, and various inhibitors of TCR signaling. J. Immunol. 179(6), 3578-3587 (2007).
105. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21(4), 589-601 (2004). (Pubitemid 39370513)
106. + T cells. Blood 109(5), 2058-2065 (2007). (Pubitemid 46348206)
107. + T regulatory cell-mediated suppression. Immunity 30(5), 636-645 (2009).
108. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl Acad. Sci. USA 105(29), 10113-10118 (2008).
109. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179(7), 4685-4693 (2007).
110. + Treg cells decrease in patients with lupus nephritis. Rheumatol. Int. DOI: 10.1007/s00296-010-1771-0 (2011) (Epub ahead of print).
111. + T cells in lupus patients. Clin. Rheumatol. 29(11), 1251-1258 (2010).
112. Becker-Merok A, Eilertsen GO, Nossent JC. Levels of transforming growth factor-β are low in systemic lupus erythematosus patients with active disease. J. Rheumatol. 37(10), 2039-2045 (2010).
113. Aggarwal N, Raveendran A, Suri V, Chopra S, Sikka P, Sharma A. Pregnancy outcome in systemic lupus erythematosus: Asia's largest single centre study. Arch. Gynecol. Obstet. 284(2), 281-285 (2010).
114. Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol. 199(2), 127 e121-e126 (2008).
115. Ogishima D, Matsumoto T, Nakamura Y, Yoshida K, Kuwabara Y. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol. Int. 50(3), 224-229 (2000). (Pubitemid 30253270)
116. Costa AM, Maximiano EB, Avvad-Portari E, Jesus NR, Levy RA, Porto LC. Contractile cells and fibrillin-1 distribution is disturbed in terminal villi of placentae from patients with preeclampsia and systemic lupus erythematosus. Placenta 27(2-3), 234-243 (2006). (Pubitemid 41763466)
117. Nayar R, Lage JM. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature. Hum. Pathol. 27(2), 201-206 (1996). (Pubitemid 26049477)
118. Ornoy A, Chen L, Silver RM, Miller RK. Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage. Birth Defects Res. A. Clin. Mol. Teratol. 70(6), 371-381 (2004). (Pubitemid 38849944)
119. Ornoy A, Yacobi S, Matalon ST et al. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus 12(7), 573-578 (2003). (Pubitemid 36890154)
120. Schwartz N, Shoenfeld Y, Barzilai O et al. Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS. Lupus 16(2), 110-120 (2007). (Pubitemid 46347933)
121. Clowse ME. Lupus activity in pregnancy. Rheum. Dis. Clin. North Am. 33(2), 237-252, v (2007). (Pubitemid 46710328)
122. Gupta R, Deepanjali S, Kumar A et al. A comparative study of pregnancy outcomes and menstrual irregularities in northern Indian patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol. Int. 30(12), 1581-1585 (2010).
123. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 52(2), 514-521 (2005). (Pubitemid 40216315)
124. Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH, Lin QD. The deregulation of regulatory T cells on interleukin-17- producing T helper cells in patients with unexplained early recurrent miscarriage. Hum. Reprod. 25(10), 2591-2596 (2010).
125. + Treg cells. Lessons from women with reproductive failure. Clin. Immunol. 136(3), 432-441 (2010).
126. Liu YS, Wu L, Tong XH et al. Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am. J. Reprod. Immunol. 65(5), 503-511 (2010).
127. + regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil. Steril. 89(3), 656-661 (2008). (Pubitemid 351335024)
128. Wang WJ, Hao CF, Yi L et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J. Reprod. Immunol. 84(2), 164-170 (2010).
129. Shima T, Sasaki Y, Itoh M et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J. Reprod. Immunol. 85(2), 121-129 (2010).
130. + T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol. 166(3), 811-822 (2005). (Pubitemid 40315638)
131. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. North. Am. 23(1), 1-13 (1997). (Pubitemid 27089252)
132. Chakravarty EF, Colon I, Langen ES et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am. J. Obstet. Gynecol. 192(6), 1897-1904 (2005). (Pubitemid 40827062)
133. Crocker I. Gabor Than Award Lecture 2006: pre-eclampsia and villous trophoblast turnover: perspectives and possibilities. Placenta 28(Suppl. A), S4-S13 (2007). (Pubitemid 46506058)
134. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol. Asp. Med. 28(2), 192-209 (2007). (Pubitemid 46843191)
135. + regulatory T lymphocytes in pregnancy and pre-eclampsia. Acta. Obstet. Gynecol. Scand. 87(2), 190-194 (2008). (Pubitemid 351171542)
136. Paeschke S, Chen F, Horn N et al. Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am. J. Reprod. Immunol. 54(6), 384-389 (2005). (Pubitemid 41748716)
137. Steinborn A, Haensch GM, Mahnke K et al. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin. Immunol. 129(3), 401-412 (2008).
138. bright) regulatory T cells in pre-eclampsia. Clin. Exp. Immunol. 149(1), 139-145 (2007). (Pubitemid 46897107)
139. Toldi G, Rigo J Jr, Stenczer B, Vasarhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol. 66(3), 223-229 (2011).
140. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia - a step forward but not the definitive answer. J. Reprod. Immunol. 82(2), 106-111 (2009).
141. Lamarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr. Hypertens. Rep. 9(6), 480-485 (2007).
142. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111(5), 649-658 (2003). (Pubitemid 36278583)
143. Qazi U, Lam C, Karumanchi SA, Petri M. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. J. Rheumatol. 35(4), 631-634 (2008). (Pubitemid 351500058)
144. Motomura Y, Kanbayashi H, Khan WI et al. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-b type II receptor gene transfer. Am. J. Phys. 288(1), G143-150 (2005).
145. Salmon JE, Heuser C, Triebwasser M et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 8(3), e1001013 (2011).
146. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 203(9), 2165-2175 (2006). (Pubitemid 44352237)
147. +CD25high regulatory T cells in patients with rheumatoid arthritis. Ann. Rheum. Dis. 67(7), 984-990 (2008). (Pubitemid 351956662)
148. Forger F, Villiger PM, Ostensen M. Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role? Arthritis Rheum. 61(2), 279-283 (2009).
149. + T-regulatory cells: toward therapy for human diseases. Immunol. Rev. 223, 391-421 (2008). (Pubitemid 351986179)
150. Gao W, Lu Y, El Essawy B, Oukka M, Kuchroo VK, Strom TB. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am. J. Transplant 7(7), 1722-1732 (2007). (Pubitemid 46905432)
151. +) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin. Immunol. 125(1), 34-42 (2007). (Pubitemid 47374537)
152. Tao R, De Zoeten EF, Ozkaynak E et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13(11), 1299-1307 (2007). (Pubitemid 350073591)
153. + T regulatory cells in murine pregnancy. J. Reprod. Immunol. 65(2), 101-110 (2005). (Pubitemid 40461928)
154. + cells. Am. J. Reprod. Immunol. 59(6), 525-534 (2008). (Pubitemid 351696295)
155. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum. Reprod. 24(11), 2703-2708 (2009).
156. Kato Y, Kuwabara T, Itoh T et al. A possible relationship between abortions and placental embolism in pregnant rabbits given human granulocyte colony-stimulating factor. J. Toxicol. Sci. 26(1), 39-50 (2001). (Pubitemid 32225214)
157. Suntharalingam G, Perry MR, Ward S et al. Cytokine storm in a Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355(10), 1018-1028 (2006). (Pubitemid 44343545)